We are live on ! Find out more
PHVS icon

Pharvaris
PHVS

35 hedge funds and large institutions have $980M invested in Pharvaris in 2024 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 11 increasing their positions, 10 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

10% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 10

4.06% more ownership

Funds ownership: 99.78% → 103.83% (+4.1%)

3% less funds holding

Funds holding: 36 → 35 (-1)

14% less capital invested

Capital invested by funds: $1.14B → $980M (-$163M)

14% less funds holding in top 10

Funds holding in top 10: 7 → 6 (-1)

14% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 7

Holders
35
Holders Change
-1
Holders Change %
-2.78%
% of All Funds
0.5%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.09%
New
6
Increased
11
Reduced
10
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
GA
General Atlantic
New York
+$36.5M
2
CC
Commodore Capital
New York
+$24.6M
3
RSCM
Rock Springs Capital Management
Maryland
+$20M
4
DM
Deerfield Management
New York
+$6.62M
5
SCM
Soleus Capital Management
Connecticut
+$4.9M

Top Sellers

Rank Fund Capital Flow
1
VP
venBio Partners
California
-$16.7M
2
BCLSI
Bain Capital Life Sciences Investors
Massachusetts
-$16M
3
NHAS
Novo Holdings A/S
Denmark
-$9.86M
4
VC
Vivo Capital
California
-$7.99M
5
Millennium Management
Millennium Management
New York
-$4.46M
Name Holding Trade Value Shares
Change 		Change in
Stake
Qube Research & Technologies (QRT)
26
Qube Research & Technologies (QRT)
United Kingdom
$696K -$57.9K -2,180 -7%
Morgan Stanley
27
Morgan Stanley
New York
$671K -$423K -15,935 -35%
Millennium Management
28
Millennium Management
New York
$474K -$4.46M -167,989 -89%
Hudson Bay Capital Management
29
Hudson Bay Capital Management
Connecticut
$463K -$1.33M -50,116 -71%
HS
30
HighVista Strategies
Massachusetts
$387K +$445K +16,750 New
JF
31
Jump Financial
Illinois
$270K +$311K +11,700 New
Bank of America
32
Bank of America
North Carolina
$180K +$207K +7,808 New
JP Morgan Chase
33
JP Morgan Chase
New York
$72.8K +$78.6K +2,960 +1,558%
BlackRock
34
BlackRock
New York
$52.4K – – –
ACM
35
ADAR1 Capital Management
Texas
$46.2K +$53.1K +2,000 New
VC
36
Vivo Capital
California
– -$7.99M -285,000 Closed
Blackstone Inc
37
Blackstone Inc
New York
– -$2.81M -100,000 Closed
UOC
38
UBS O'Connor
Illinois
– -$505K -18,000 Closed
SSA
39
Schonfeld Strategic Advisors
New York
– -$348K -12,400 Closed
Two Sigma Investments
40
Two Sigma Investments
New York
– -$230K -8,198 Closed
QL
41
Quarry LP
New York
– -$21K -750 Closed
PSC
42
Piper Sandler & Co
Minnesota
– -$5.08K -181 Closed
1
2

PHVS Hedge Fund Activity: Q1 2024 in Review

35 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Pharvaris (PHVS) for Q1 2024, worth a combined $980M — down 14% from $1.14B a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of PHVS and 6 opened new positions — a net loss of 1 holder — while 10 trimmed existing stakes and 11 added.

The largest buyer was General Atlantic, adding an estimated $36.5M. The largest seller was venBio Partners, cutting an estimated $16.7M.

  • 35 institutional investors held Pharvaris (PHVS) as of Q1 2024, down from 36 in Q4 2023.
  • Funds reported $980M of Pharvaris stock for Q1 2024, down 14% quarter-over-quarter.
  • 6 funds opened new Pharvaris positions in Q1 2024 and 7 closed out, a net change of -1 holder.
  • The largest Pharvaris buyer in Q1 2024 was General Atlantic, an estimated $36.5M added.
  • The largest Pharvaris seller in Q1 2024 was venBio Partners, an estimated $16.7M sold.

Based on aggregated 13F filings for Q1 2024.